ID   BECN1_RAT               Reviewed;         448 AA.
AC   Q91XJ1;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   02-OCT-2024, entry version 159.
DE   RecName: Full=Beclin-1;
DE   AltName: Full=Coiled-coil myosin-like BCL2-interacting protein;
DE   AltName: Full=Protein GT197;
DE   Contains:
DE     RecName: Full=Beclin-1-C 35 kDa;
DE   Contains:
DE     RecName: Full=Beclin-1-C 37 kDa;
GN   Name=Becn1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Ovary;
RA   Paredes A.H., Tapia V., Ojeda S.R.;
RT   "Beclin mRNA in the developing rat ovary.";
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH VMP1.
RX   PubMed=17724469; DOI=10.1038/sj.onc.1210743;
RA   Sauermann M., Sahin O., Sultmann H., Hahne F., Blaszkiewicz S., Majety M.,
RA   Zatloukal K., Fuzesi L., Poustka A., Wiemann S., Arlt D.;
RT   "Reduced expression of vacuole membrane protein 1 affects the invasion
RT   capacity of tumor cells.";
RL   Oncogene 27:1320-1326(2008).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 174-264, SUBUNIT, DOMAIN, AND
RP   MUTAGENESIS OF LEU-178; GLU-189; LEU-192; LEU-196; ALA-217; GLU-224;
RP   ALA-255 AND LEU-259.
RX   PubMed=22314358; DOI=10.1038/ncomms1648;
RA   Li X., He L., Che K.H., Funderburk S.F., Pan L., Pan N., Zhang M., Yue Z.,
RA   Zhao Y.;
RT   "Imperfect interface of Beclin1 coiled-coil domain regulates homodimer and
RT   heterodimer formation with Atg14L and UVRAG.";
RL   Nat. Commun. 3:662-662(2012).
CC   -!- FUNCTION: Plays a central role in autophagy. Acts as a core subunit of
CC       the PI3K complex that mediates formation of phosphatidylinositol 3-
CC       phosphate; different complex forms are believed to play a role in
CC       multiple membrane trafficking pathways: PI3KC3-C1 is involved in
CC       initiation of autophagosomes and PI3KC3-C2 in maturation of
CC       autophagosomes and endocytosis. Involved in regulation of degradative
CC       endocytic trafficking and required for the abscission step in
CC       cytokinesis, probably in the context of PI3KC3-C2. Essential for the
CC       formation of PI3KC3-C2 but not PI3KC3-C1 PI3K complex forms. Involved
CC       in endocytosis. May play a role in antiviral host defense (By
CC       similarity). {ECO:0000250|UniProtKB:O88597,
CC       ECO:0000250|UniProtKB:Q14457}.
CC   -!- FUNCTION: Beclin-1-C 35 kDa localized to mitochondria can promote
CC       apoptosis; it induces the mitochondrial translocation of BAX and the
CC       release of proapoptotic factors. {ECO:0000250|UniProtKB:O88597,
CC       ECO:0000250|UniProtKB:Q14457}.
CC   -!- SUBUNIT: A homodimeric form is proposed to exist; this metastable form
CC       readily transits to ATG14- or UVRAG-containing complexes with
CC       BECN1:UVRAG being more stable than BECN1:ATG14 (PubMed:22314358).
CC       Component of the PI3K (PI3KC3/PI3K-III/class III phosphatidylinositol
CC       3-kinase) complex the core of which is composed of the catalytic
CC       subunit PIK3C3, the regulatory subunit PIK3R4 and BECN1 associating
CC       with additional regulatory/auxiliary subunits to form alternative
CC       complex forms. Alternative complex forms containing a fourth regulatory
CC       subunit in a mutually exclusive manner are PI3K complex I (PI3KC3-C1)
CC       containing ATG14, and PI3K complex II (PI3KC3-C2) containing UVRAG.
CC       PI3KC3-C1 displays a V-shaped architecture with PIK3R4 serving as a
CC       bridge between PIK3C3 and the ATG14:BECN1 subcomplex. Both, PI3KC3-C1
CC       and PI3KC3-C2, can associate with further regulatory subunits, such as
CC       RUBCN, SH3GLB1/Bif-1 and AMBRA1. PI3KC3-C1 probably associates with
CC       PIK3CB. Forms a complex with PPP2CA and AMBRA1; AMBRA1 and BECN1
CC       components of the complex regulate MYC stability via different pathways
CC       (By similarity). Component of the complex, at least composed of LRPPRC,
CC       BECN1 and BCL2; the interactions prevent BECN1 from forming an
CC       autophagy-inducing complex with PIK3C3 (By similarity). Interacts with
CC       AMBRA1, GOPC, GRID2. Interacts with BCL2 and BCL2L1 isoform Bcl-X(L);
CC       the interaction inhibits BECN1 function in promoting autophagy by
CC       interfering with the formation of the PI3K complex. Interacts with
CC       cytosolic HMGB1; inhibits the interaction of BECN1 and BCL2 leading to
CC       promotion of autophagy. Interacts with USP10, USP13, DAPK1, RAB39A.
CC       Interacts with SLAMF1 (By similarity). Interacts with the poly-Gln
CC       domain of ATXN3; the interaction causes deubiquitination at Lys-400 and
CC       stabilizes BECN1. Interacts with VMP1 (PubMed:17724469). Interacts with
CC       TRIM5; the interaction causes activation of BECN1 by causing its
CC       dissociation from its inhibitors BCL2 and TAB2 (By similarity).
CC       Interacts with active ULK1 (phosphorylated on 'Ser-317') and MEFV
CC       simultaneously (By similarity). Interacts with WDR81 and WDR91;
CC       negatively regulates the PI3 kinase/PI3K activity associated with
CC       endosomal membranes (By similarity). Interacts with LAPTM4B; competes
CC       with EGFR for LAPTM4B binding; regulates EGFR activity (By similarity).
CC       Interacts with TRIM50 (By similarity). Interacts with TRIM16 (By
CC       similarity). Interacts with ATG14; this interaction is increased in the
CC       absence of TMEM39A (By similarity). Interacts with WASHC1; preventing
CC       interaction with AMBRA1 and the DCX(AMBRA1) complex and subsequent
CC       ubiquitination (By similarity). Interacts with TRIM17 (By similarity).
CC       Interacts with BCL2L10/BCL-B (via BH1 domain) (By similarity).
CC       Interacts with SH3BGRL (By similarity). Interacts with IRGM; enhancing
CC       BECN1-interacting partners and influencing the composition of the BECN1
CC       complex (By similarity). Interacts with ARMC3 (By similarity).
CC       Interacts with LRPPRC (By similarity). {ECO:0000250|UniProtKB:O88597,
CC       ECO:0000250|UniProtKB:Q14457, ECO:0000269|PubMed:17724469}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O88597}. Golgi
CC       apparatus, trans-Golgi network membrane {ECO:0000250|UniProtKB:Q14457};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:Q14457}. Endosome
CC       membrane {ECO:0000250|UniProtKB:Q14457}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q14457}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q14457}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q14457}. Mitochondrion membrane
CC       {ECO:0000250|UniProtKB:Q14457}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q14457}. Cytoplasmic vesicle, autophagosome
CC       {ECO:0000305}. Note=Interaction with ATG14 promotes translocation to
CC       autophagosomes. Expressed in dendrites and cell bodies of cerebellar
CC       Purkinje cells. {ECO:0000250|UniProtKB:O88597,
CC       ECO:0000250|UniProtKB:Q14457}.
CC   -!- SUBCELLULAR LOCATION: [Beclin-1-C 35 kDa]: Mitochondrion
CC       {ECO:0000250|UniProtKB:O88597, ECO:0000250|UniProtKB:Q14457}. Nucleus
CC       {ECO:0000250|UniProtKB:Q14457}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q14457}.
CC   -!- SUBCELLULAR LOCATION: [Beclin-1-C 37 kDa]: Mitochondrion
CC       {ECO:0000250|UniProtKB:O88597}.
CC   -!- DOMAIN: The C-terminal evolutionary conserved domain (ECD) contains
CC       poly-Gln-binding domains such as the ATXN3 poly-Gln motif, consistent
CC       with structural docking models revealing two highly scored poly-Gln-
CC       binding pockets in the ECD (By similarity). As some binding is observed
CC       with BECN1 lacking the ECD, other domains of BECN1 may also interact
CC       with ATXN3 (By similarity). {ECO:0000250|UniProtKB:Q14457}.
CC   -!- DOMAIN: The coiled coil domain can form antiparallel homodimers and
CC       mediates dimerization with the coiled coil domains of ATG14 or UVRAG
CC       involved in the formation of PI3K complexes.
CC       {ECO:0000269|PubMed:22314358}.
CC   -!- PTM: Phosphorylation at Thr-117 by DAPK1 reduces its interaction with
CC       BCL2 and BCL2L1 and promotes induction of autophagy. In response to
CC       autophagic stimuli, phosphorylated at serine residues by AMPK in an
CC       ATG14-dependent manner, and this phosphorylation is critical for
CC       maximally efficient autophagy. {ECO:0000250|UniProtKB:O88597,
CC       ECO:0000250|UniProtKB:Q14457}.
CC   -!- PTM: Polyubiquitinated by NEDD4, both with 'Lys-11'- and 'Lys-63'-
CC       linkages (By similarity). 'Lys-11'-linked polyubiquitination leads to
CC       degradation and is enhanced when the stabilizing interaction partner
CC       VPS34 is depleted (By similarity). Deubiquitinated by USP10 and USP13,
CC       leading to stabilize the PIK3C3/VPS34-containing complexes (By
CC       similarity). Polyubiquitinated at Lys-400 with 'Lys-48'-linkages (By
CC       similarity). 'Lys-48'-linked polyubiquitination of Lys-400 leads to
CC       degradation (By similarity). Deubiquitinated by ATXN3, leading to
CC       stabilization (By similarity). Ubiquitinated at Lys-435 via 'Lys-63'-
CC       linkage by the DCX(AMBRA1) complex, thereby increasing the association
CC       between BECN1 and PIK3C3 to promote PIK3C3 activity (By similarity).
CC       'Lys-48'-linked ubiquitination by RNF216 leads to proteasomal
CC       degradation and autophagy inhibition (By similarity).
CC       {ECO:0000250|UniProtKB:Q14457}.
CC   -!- PTM: Proteolytically processed by caspases including CASP8 and CASP3;
CC       the C-terminal fragments lack autophagy-inducing capacity and are
CC       proposed to induce apoptosis. Thus the cleavage is proposed to be an
CC       determinant to switch from autophagy to apoptosis pathways affecting
CC       cellular homeostasis including viral infections and survival of tumor
CC       cells. {ECO:0000250|UniProtKB:O88597, ECO:0000250|UniProtKB:Q14457}.
CC   -!- MISCELLANEOUS: Expanded poly-Gln tracts inhibit ATXN3-BECN1
CC       interaction, decrease BECN1 levels and impair starvation-induced
CC       autophagy (By similarity). {ECO:0000250|UniProtKB:Q14457}.
CC   -!- SIMILARITY: Belongs to the beclin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY033824; AAK56548.1; -; mRNA.
DR   EMBL; BC074011; AAH74011.1; -; mRNA.
DR   RefSeq; NP_001029289.1; NM_001034117.1.
DR   RefSeq; NP_446191.1; NM_053739.2.
DR   PDB; 3Q8T; X-ray; 1.90 A; A/B=174-264.
DR   PDBsum; 3Q8T; -.
DR   AlphaFoldDB; Q91XJ1; -.
DR   SMR; Q91XJ1; -.
DR   BioGRID; 250376; 2.
DR   DIP; DIP-61888N; -.
DR   IntAct; Q91XJ1; 1.
DR   STRING; 10116.ENSRNOP00000071966; -.
DR   iPTMnet; Q91XJ1; -.
DR   PhosphoSitePlus; Q91XJ1; -.
DR   PaxDb; 10116-ENSRNOP00000027868; -.
DR   Ensembl; ENSRNOT00000082010.2; ENSRNOP00000071966.1; ENSRNOG00000020513.8.
DR   Ensembl; ENSRNOT00055056789; ENSRNOP00055046889; ENSRNOG00055032831.
DR   Ensembl; ENSRNOT00060023142; ENSRNOP00060018342; ENSRNOG00060013552.
DR   Ensembl; ENSRNOT00065053430; ENSRNOP00065043920; ENSRNOG00065030974.
DR   GeneID; 114558; -.
DR   KEGG; rno:114558; -.
DR   UCSC; RGD:620190; rat.
DR   AGR; RGD:620190; -.
DR   CTD; 8678; -.
DR   RGD; 620190; Becn1.
DR   eggNOG; KOG2751; Eukaryota.
DR   GeneTree; ENSGT00390000008164; -.
DR   HOGENOM; CLU_024219_4_1_1; -.
DR   InParanoid; Q91XJ1; -.
DR   OMA; EWDVYKA; -.
DR   OrthoDB; 11439at2759; -.
DR   PhylomeDB; Q91XJ1; -.
DR   TreeFam; TF314282; -.
DR   Reactome; R-RNO-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-RNO-1632852; Macroautophagy.
DR   Reactome; R-RNO-5689880; Ub-specific processing proteases.
DR   EvolutionaryTrace; Q91XJ1; -.
DR   PRO; PR:Q91XJ1; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000020513; Expressed in colon and 20 other cell types or tissues.
DR   GO; GO:0005776; C:autophagosome; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0032473; C:cytoplasmic side of mitochondrial outer membrane; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0016604; C:nuclear body; IEA:Ensembl.
DR   GO; GO:0045335; C:phagocytic vesicle; ISO:RGD.
DR   GO; GO:0000407; C:phagophore assembly site; IBA:GO_Central.
DR   GO; GO:0035032; C:phosphatidylinositol 3-kinase complex, class III; ISS:UniProtKB.
DR   GO; GO:0034271; C:phosphatidylinositol 3-kinase complex, class III, type I; IBA:GO_Central.
DR   GO; GO:0034272; C:phosphatidylinositol 3-kinase complex, class III, type II; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:RGD.
DR   GO; GO:0051020; F:GTPase binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:RGD.
DR   GO; GO:0050435; P:amyloid-beta metabolic process; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0000045; P:autophagosome assembly; IMP:RGD.
DR   GO; GO:0097352; P:autophagosome maturation; ISO:RGD.
DR   GO; GO:0006914; P:autophagy; IMP:RGD.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0071275; P:cellular response to aluminum ion; IEP:RGD.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; IEP:RGD.
DR   GO; GO:0071280; P:cellular response to copper ion; IEP:RGD.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IEP:RGD.
DR   GO; GO:0042149; P:cellular response to glucose starvation; ISS:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0006995; P:cellular response to nitrogen starvation; IBA:GO_Central.
DR   GO; GO:0090650; P:cellular response to oxygen-glucose deprivation; IEP:RGD.
DR   GO; GO:0002753; P:cytoplasmic pattern recognition receptor signaling pathway; ISO:RGD.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045022; P:early endosome to late endosome transport; ISS:UniProtKB.
DR   GO; GO:0043652; P:engulfment of apoptotic cell; ISO:RGD.
DR   GO; GO:0007254; P:JNK cascade; IMP:RGD.
DR   GO; GO:0045324; P:late endosome to vacuole transport; IBA:GO_Central.
DR   GO; GO:0007040; P:lysosome organization; ISO:RGD.
DR   GO; GO:0016236; P:macroautophagy; ISS:UniProtKB.
DR   GO; GO:0000423; P:mitophagy; ISO:RGD.
DR   GO; GO:0007080; P:mitotic metaphase chromosome alignment; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:1902902; P:negative regulation of autophagosome assembly; ISO:RGD.
DR   GO; GO:0010507; P:negative regulation of autophagy; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:1905672; P:negative regulation of lysosome organization; IMP:RGD.
DR   GO; GO:0043069; P:negative regulation of programmed cell death; ISO:RGD.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0048666; P:neuron development; ISO:RGD.
DR   GO; GO:0038066; P:p38MAPK cascade; IMP:RGD.
DR   GO; GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; ISO:RGD.
DR   GO; GO:1902425; P:positive regulation of attachment of mitotic spindle microtubules to kinetochore; ISO:RGD.
DR   GO; GO:2000786; P:positive regulation of autophagosome assembly; IMP:RGD.
DR   GO; GO:0010508; P:positive regulation of autophagy; IMP:RGD.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; ISO:RGD.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0062029; P:positive regulation of stress granule assembly; IMP:RGD.
DR   GO; GO:0065003; P:protein-containing complex assembly; ISO:RGD.
DR   GO; GO:0032801; P:receptor catabolic process; ISO:RGD.
DR   GO; GO:0010506; P:regulation of autophagy; ISO:RGD.
DR   GO; GO:0032465; P:regulation of cytokinesis; ISS:UniProtKB.
DR   GO; GO:0016241; P:regulation of macroautophagy; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0010040; P:response to iron(II) ion; IEP:RGD.
DR   GO; GO:0010288; P:response to lead ion; IEP:RGD.
DR   GO; GO:0098780; P:response to mitochondrial depolarisation; ISO:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0051707; P:response to other organism; ISO:RGD.
DR   GO; GO:0033197; P:response to vitamin E; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0060395; P:SMAD protein signal transduction; IDA:RGD.
DR   Gene3D; 6.10.250.3110; -; 1.
DR   Gene3D; 1.10.418.40; Autophagy protein 6/Beclin 1; 1.
DR   InterPro; IPR007243; Atg6/Beclin.
DR   InterPro; IPR038274; Atg6/Beclin_C_sf.
DR   InterPro; IPR041691; Atg6/beclin_CC.
DR   InterPro; IPR040455; Atg6_BARA.
DR   InterPro; IPR029318; BH3_dom.
DR   PANTHER; PTHR12768; BECLIN 1; 1.
DR   PANTHER; PTHR12768:SF6; BECLIN-1; 1.
DR   Pfam; PF04111; APG6; 1.
DR   Pfam; PF17675; APG6_N; 1.
DR   Pfam; PF15285; BH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Antiviral defense; Apoptosis; Autophagy;
KW   Cell cycle; Cell division; Coiled coil; Cytoplasm; Cytoplasmic vesicle;
KW   Endoplasmic reticulum; Endosome; Golgi apparatus; Isopeptide bond;
KW   Membrane; Mitochondrion; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN           1..448
FT                   /note="Beclin-1"
FT                   /id="PRO_0000316290"
FT   CHAIN           132..448
FT                   /note="Beclin-1-C 37 kDa"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT                   /id="PRO_0000435044"
FT   CHAIN           148..448
FT                   /note="Beclin-1-C 35 kDa"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT                   /id="PRO_0000435045"
FT   REGION          47..72
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          110..157
FT                   /note="Interaction with BCL2 and BCL2L1 isoform Bcl-X(L)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   REGION          243..448
FT                   /note="Evolutionary conserved domain (ECD)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   REGION          423..448
FT                   /note="Required for membrane-association"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   COILED          140..267
FT                   /evidence="ECO:0000255"
FT   MOTIF           106..125
FT                   /note="BH3"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MOD_RES         88
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MOD_RES         91
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MOD_RES         94
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:O88597"
FT   MOD_RES         117
FT                   /note="Phosphothreonine; by DAPK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   CROSSLNK        400
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   CROSSLNK        435
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MUTAGEN         178
FT                   /note="L->A: Disrupts homodimerization, no effect on
FT                   interaction with ATG14 and UVRAG; when associated with A-
FT                   192."
FT                   /evidence="ECO:0000269|PubMed:22314358"
FT   MUTAGEN         178
FT                   /note="L->A: Disrupts homodimerization, no effect on
FT                   interaction with ATG14 and UVRAG; when associated with A-
FT                   196."
FT                   /evidence="ECO:0000269|PubMed:22314358"
FT   MUTAGEN         178
FT                   /note="L->A: Disrupts homodimerization, no effect on
FT                   interaction with ATG14 and UVRAG; when associated with A-
FT                   259."
FT                   /evidence="ECO:0000269|PubMed:22314358"
FT   MUTAGEN         189
FT                   /note="E->L: Decreases interaction with ATG14, no effect on
FT                   interaction with UVRAG; when associated with L-217, L-224
FT                   and L-255."
FT                   /evidence="ECO:0000269|PubMed:22314358"
FT   MUTAGEN         192
FT                   /note="L->A: Disrupts homodimerization, no effect on
FT                   interaction with ATG14 and UVRAG; when associated with A-
FT                   178."
FT                   /evidence="ECO:0000269|PubMed:22314358"
FT   MUTAGEN         196
FT                   /note="L->A: Disrupts homodimerization, no effect on
FT                   interaction with ATG14 and UVRAG; when associated with A-
FT                   178."
FT                   /evidence="ECO:0000269|PubMed:22314358"
FT   MUTAGEN         217
FT                   /note="A->L: Decreases interaction with ATG14, no effect on
FT                   interaction with UVRAG; when associated with L-189, L-224
FT                   and L-255."
FT                   /evidence="ECO:0000269|PubMed:22314358"
FT   MUTAGEN         224
FT                   /note="E->L: Decreases interaction with ATG14, no effect on
FT                   interaction with UVRAG; when associated with L-189, L-217
FT                   and L-255."
FT                   /evidence="ECO:0000269|PubMed:22314358"
FT   MUTAGEN         255
FT                   /note="A->L: Decreases interaction with ATG14, no effect on
FT                   interaction with UVRAG; when associated with L-189, L-217
FT                   and L-224."
FT                   /evidence="ECO:0000269|PubMed:22314358"
FT   MUTAGEN         259
FT                   /note="L->A: Disrupts homodimerization, no effect on
FT                   interaction with ATG14 and UVRAG; when associated with A-
FT                   178."
FT                   /evidence="ECO:0000269|PubMed:22314358"
FT   HELIX           174..263
FT                   /evidence="ECO:0007829|PDB:3Q8T"
SQ   SEQUENCE   448 AA;  51557 MW;  34981BE560F3354B CRC64;
     MEGSKASSST MQVSFVCQRC SQPLKLDTSF KILDRVTIQE LTAPLLTTAQ AKPGESQEEE
     ANSGEEPFIE TRQDGVSRRF IPPARMMSTE SANSFTLIGE ASDGGTMENL SRRLKVTGDL
     FDIMSGQTDV DHPLCEECTD TLLDQLDTQL NVTENECQNY KRCLEMLEQM NEGDSEQLQR
     ELKELALEEE RLIQELEDVE KNRKVVAENL EKVQAEAERL DQEEAQYQRE YSEFKRQQLE
     LDDELKSVEN QMRYAQMQLD KLKKTNVFNA TFHIWHSGQF GTINNFRLGR LPSAPVEWNE
     INAAWGQTVL LLHALANKMG LKFQRYRLVP YGNHSYLESL TDKSKELPLY CSGGLRFFWD
     NKFDHAMVAF LDCVQQFKEE VEKGETRFCL PYRMDVEKGK IEDTGGSGGS YSIKTQFNSE
     EQWTKALKFM LTNLKWGLAW VSSQFYNK
//
